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ABSTRACT 
 
In skeletal muscle, sarcoplasmic reticulum (SR) calcium release is controlled by the plasma 
membrane voltage through interactions between the voltage sensing dihydropyridine receptor 
(DHPr) and the ryanodine receptor (RYr) calcium release channel. Maurocalcine (MCa), a 
scorpion toxin peptide presenting some homology with a segment of a cytoplasmic loop of the 
DHPr has been previously shown to strongly affect the activity of the isolated RYr. We 
injected MCa into mouse skeletal muscle fibers and measured intracellular calcium under 
voltage-clamp conditions. Voltage activated calcium transients exhibited similar properties in 
control and in MCa-injected fibers during the depolarizing pulses and the voltage dependence 
of calcium release was similar under the two conditions. However, MCa was responsible for a 
pronounced sustained phase of Ca2+ elevation that proceeded for seconds following 
membrane repolarization, with no concurrent alteration of the membrane current. The 
magnitude of the underlying uncontrolled extra-phase of Ca2+ release correlated well with the 
peak calcium release during the pulse. Results suggest that MCa binds to RYr that open upon 
membrane depolarization and that this interaction specifically alters the process of 
repolarization-induced closure of the channels.  
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INTRODUCTION 
 
Optimal control of voluntary movement and force production relies ultimately on the 
efficacy of excitation-contraction (e-c) coupling of skeletal muscle. The contraction of a 
skeletal muscle fiber is rapidly initiated and stopped by changes in the voltage across the 
plasma membrane, physiologically an action potential or a train of action potentials. The 
coupling between membrane depolarization and the resulting transient rise in cytoplasmic 
[Ca2+] that activates the contractile machinery is ensured by two types of ion channel proteins 
facing each other, across an ~15 nm wide gap at the triadic junction; these two are the DHPr 
in the plasma/transverse-tubule membrane, that senses the changes in voltage and the RYr 
calcium release channel in the SR membrane. The opening and closure of the RYr calcium 
channel is subordinated to voltage-dependent conformational changes of the DHPr but the 
details of the functional interactions between the two still remain obscure. Since the early 
nineties several lines of evidence have highlighted the importance of the II-III cytoplasmic 
loop of the α1 subunit of the DHPr in these interactions (1-3). Within this loop, a 20 amino 
acid fragment named domain A has received particular attention because the corresponding 
isolated peptide is capable of modulating Ca2+ release from SR preparations as well as the 
activity of the isolated RYr channel (4-9). The situation is, however, not so clear since both 
activating and inhibiting effects have been reported. Furthermore the relevance and exact 
function of this segment during physiological e-c coupling has been seriously challenged by 
negative results in studies that used expression of chimeras of the α1 subunit in dysgenic 
myotubes (10-12).  
 
MCa is a 33 amino acid toxin isolated from the venom of the scorpion Scorpio Maurus 
Palmatus (13). MCa is very similar to Imperatoxin A (IpTxa), a venom toxin from another 
scorpion and both share some sequence homology and a striking similarity in the spatial 
orientation of positively charged residues with domain A of the II-III loop of the DHPr (see 
14, 15). Interestingly both MCa and IpTxa can enhance [3H] ryanodine binding to SR 
vesicles, increase ion flow through isolated ryanodine receptors, elicit Ca2+ release from SR 
vesicles and modulate the properties of elementary calcium release events detected in 
permeabilized muscle fibers (6, 13, 14, 16, 17, 18, 19). In the case of MCa, there is also clear 
evidence that it binds to the same site of the RYr as domain A (20). This potentially makes 
these two toxins highly interesting tools to characterize the still elusive role of domain A of 
the DHPr in the e-c coupling process. Here we injected MCa into adult skeletal muscle fibers 
from mouse and measured intracellular [Ca2+] under voltage-clamp conditions. Results show 
that MCa dramatically affects the process of repolarization-induced closure of the RYrs 
during physiological e-c coupling. 
 
METHODS 
 
Preparation of the muscle fibers 
Experiments were performed on single fibers isolated from the flexor digitorum brevis (fdb) 
muscles from 4-8 weeks-old Swiss OF1 mice. All experiments were performed in accordance 
with the guidelines of the French Ministry of Agriculture (87/848) and of the European 
Community (86/609/EEC). Procedures for enzymatic isolation of single muscle fibers, partial 
insulation of the fibers with silicone grease and intracellular micro-injection of the dye indo-1, 
were as described previously (21-24). In brief, the major part of a single fiber was electrically 
insulated with silicone grease so that whole-cell voltage clamp could be achieved on a short 
portion of the fiber extremity. Prior to voltage-clamp, indo-1 was introduced into the 
myoplasm through local pressure micro-injection. Intracellular loading of either MCa or of its 
mutated analogue [Ala24]MCa was achieved by co-injection with the dye; peptides were 
present in the micro-injected solution at a concentration of 100 µM. Following diffusion and 
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equilibration within the cytoplasm, this was believed to achieve a final cytoplasmic 
concentration within the 10 micromolar range (for details concerning micro-injections see 
25). It should be noted that the effects seen in the present study required two orders of 
magnitude more MCa than in experiments in more isolated systems. One likely reason for this 
discrepancy is that most of the injected MCa was bound to sites within the fiber so that the 
free MCa concentration was very much lower than the above estimated level. 
In a separate series of experiments we also tested the effect of the injection of a 
synthetic domain A peptide corresponding to residues Thr671-Leu690 of the α1 subunit of the 
DHPr; this peptide was used at a concentration of 2 mM in the injecting pipette. 
Control data were always obtained from fibers issued from the same muscles as the toxin- or 
peptide-injected fibers. The number of fibers tested under a given set of conditions was 
always obtained from muscles taken from at least 3 different animals. 
All experiments were performed at room temperature (20-22 °C). 
 
Electrophysiology 
An RK-400 patch-clamp amplifier (Bio-Logic, Claix, France) was used in whole-cell 
configuration. Command voltage pulse generation and data acquisition were done using 
commercial software (Biopatch Acquire, Bio-Logic) driving an A/D, D/A converter (Lab 
Master DMA board, Scientific Solutions Inc., Mentor, OH, USA). Analog compensation was 
systematically used to decrease the effective series resistance. Voltage-clamp was performed 
with a microelectrode filled with the intracellular-like solution (see Solutions). The tip of the 
microelectrode was inserted through the silicone, within the insulated part of the fiber. 
Membrane depolarizations (or series of depolarizations) were applied every 30 s from a 
holding command potential of -80 mV. 
 
Fluorescence measurements 
The optical set-up and the procedures used for indo-1 fluorescence measurements were as 
described previously (21, 22, 23, 26). In brief, a Nikon Diaphot epifluorescence microscope 
was used in diafluorescence mode. The beam of light from a high-pressure mercury bulb set 
on the top of the microscope was passed through a 335 nm interference filter and focused onto 
the preparation. The emitted indo-1 fluorescence light was collected by a 40x objective and 
simultaneously detected at 405 ± 5 nm (F405) and 470 ± 5 nm (F470) by two photomultipliers. 
The fluorescence measurement field was 40 µm in diameter and the silicone-free extremity of 
each tested fiber was placed in the middle of the field. Background fluorescence at both 
emission wavelengths was measured next to each tested fiber and was then subtracted from all 
measurements. 
 
Calibration of the indo-1 response and [Ca2+]i calculation 
The standard ratio method was used with the parameters: R=F405/F470, and Rmin, Rmax, 
KD, β having their usual definition. Results were either expressed in terms of indo-1 percent 
saturation or in actual free calcium concentration (for details of calculation, see 21, 25). In 
vivo values for Rmin, Rmax and β were measured using procedures described previously (22, 
23). 
 
Calculation of the rate of calcium release 
The method used to estimate the SR calcium release flux from the indo-1 transients was 
previously described (24): the time derivative of the total myoplasmic Ca2+ was calculated 
from the occupancy of the main intracellular calcium binding sites (27). The model included 
troponin C binding sites with a total sites concentration TNtotal of  250 µM, an “on” rate 
constant kon, CaTN of 0.0575 µM-1.ms-1 and an “off” rate constant koff, CaTN of 0.115 ms-1; Ca-Mg 
binding sites on parvalbumin with a total sites concentration PVtotal = 700 µM, “on” rate 
constant for Ca2+ kon, CaPV = 0.125 µM-1.ms-1, “off” rate constant for Ca2+ koff, CaPV = 5.10-4 ms-
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1, “on” rate constant for Mg2+ kon, MgPV = 3.3.10-5 µM-1.ms-1, “off” rate constant for Mg2+ koff, 
MgPV = 3.10-3 ms-1. The rate of calcium transport across the SR membrane was assumed to be 
proportional to the fractional occupancy of the SR pump sites with a dissociation constant Kd 
Capump of 2 µM and a maximum pump rate of 3 µM.ms-1. Resting [Mg2+] was assumed to be 
1.5 mM. Indo-1 was assumed to be present at 100 µM with values for the “on” and “off” rate 
constants of the Ca-indo-1 binding reaction of 1.108 M-1.s-1 and 30 s-1, respectively. 
 
Simulation of indo-1 transients 
Simulations of [Ca-indo-1] transients elicited by membrane depolarizations were performed 
according to the procedure of Timmer et al. (28), as described in Collet et al. (23). In brief, a 
synthetic Ca2+ release rate waveform was fed into a calcium distribution model that 
reproduced the main features of Ca2+ regulation in a muscle fiber. The model included the 
intracellular Ca2+ binding sites and uptake mechanism described in the previous paragraph. 
Resting [Ca2+] was assumed to be 0.1 µM.  
 
Solutions 
The intracellular-like solution contained (in mM) 120 K-glutamate, 5 Na2-ATP, 5 Na2-
phosphocreatine, 5.5 MgCl2, 5 glucose, 5 HEPES adjusted to pH 7.20 with K-OH. The 
standard extracellular solution contained (in mM) 140 TEA-methanesulfonate, 2.5 CaCl2, 2 
MgCl2, 10 TEA-HEPES and 0.002 tetrodotoxin, pH 7.20.  
 
Statistics 
Least-squares fits were performed using a Marquardt-Levenberg algorithm routine included in 
Microcal Origin (Originlab, Northampton, MA, USA). Data values are presented as means ± 
S.E.M. for n fibers, where n is specified in Results. Statistical significance was determined 
using a Student’s t-test assuming significance for P < 0.05. 
 
 
RESULTS 
 
The effect of MCa and of its mutated inactive analog [Ala24]MCa (14) were tested on 
membrane current and intracellular calcium measured from isolated mouse skeletal muscle 
fibers. The mean initial resting [Ca2+] level did not significantly differ between control fibers 
(58 ± 12 nM, n=16), MCa-injected fibers (49 ± 6 nM, n=22) and [Ala24]MCa- injected fibers 
(62 ± 11 nM, n=7), indicating that the peptides did not chronically alter the intracellular 
resting Ca2+ homeostasis. However, the presence of MCa produced a very remarkable change 
in the properties of the voltage activated Ca2+ transients. This is illustrated in Fig. 1A which 
shows superimposed indo-1 calcium signals that were elicited by successive step membrane 
depolarizations of 10, 30 and 50 ms duration to +10 mV in a control fiber, an MCa-injected 
fiber and an [Ala24]MCa- injected fiber. In all fibers, and as classically described, voltage 
activated SR Ca2+ release produced a rapid rise in the calcium indicator saturation level and 
the signal remained elevated during the pulse. In the control fiber and in the [Ala24]MCa- 
injected fiber, membrane repolarization turned off Ca2+ release and as a consequence the 
indo-1 signal returned towards its resting level with a time constant in the hundred of 
milliseconds range, as typically observed under normal conditions (see for instance 21, 22, 
26). In the MCa-injected fiber, there was also a repolarization-induced sharp decay of the 
indo-1 signal, but surprisingly the decline was only partial and the signal was still very much 
elevated at the end of the records. Pulses of 10 and 30 ms duration to + 10 mV were applied 
in several fibers issued from the same muscles upon these three conditions. The graphs in Fig. 
1 give mean values for the corresponding baseline [Ca2+] level (Fig. 1B), the peak ∆[Ca2+] 
during the pulse (Fig. 1C), the ∆[Ca2+] measured at the time of the end of the records shown 
in Fig. 1A (Fig. 1D, that is 0.92 s after the onset of the pulses, which we will refer to as 1 s 
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after the pulses for simplicity) and the ratio of ∆[Ca2+] measured 1 s after the pulse (∆[Ca2+]1s) 
to the preceding peak ∆[Ca2+] (Fig. 1E). Ca2+ values were obtained without correction for the 
kinetics of indo-1 Ca-binding. Fibers were all challenged successively with 10 and 30 ms-
long pulses, with records taken either as shown in Fig. 1A or with longer records taken at a 
slower sampling rate (as shown in Fig. 2). There was no significant difference in the baseline 
[Ca2+] (Fig. 1B) and peak ∆[Ca2+] level (Fig. 1C) between the three groups of fibers. 
Conversely, the mean absolute ∆[Ca2+] measured 1 s after the pulse was significantly larger, 
for both pulse duration, in the MCa-injected fibers than in either the control fibers or the 
[Ala24]MCa-injected fibers (Fig. 1D). In average the ∆[Ca2+]1 s value was ~30 % of the 
preceding peak ∆[Ca2+] in the MCa-injected fibers, and ~5 % in the control and in the 
[Ala24]MCa-injected fibers (Fig. 1E). The fact that this ratio exhibited a similar value for the 
two pulses duration in the presence of MCa indicates that the amplitude of the phenomenon 
correlated well with the preceding extent of Ca2+ release activation during the pulse. 
In Fig. 1A, it is noticeable that within the 30 s period of time between two consecutive 
pulses, [Ca2+] had eventually returned to its initial resting level as witnessed by the absence of 
change in the baseline indo-1 saturation level. The MCa-induced sustained post-pulse [Ca2+] 
level was thus a transient phenomenon. Examples of its overall time course are illustrated in 
Fig. 2 which shows 15 s-long indo-1 saturation records in a control fiber and in two MCa-
injected fibers. Fibers were depolarized by short pulses to +10 mV of various duration. 
Although somewhat variable in pattern and amplitude, the post-pulse [Ca2+] elevation 
observed in the presence of MCa always lasted for seconds and vanished with an extremely 
slow time course. 
This long-lasting elevated intracellular [Ca2+] level had to result from either an 
additional influx of Ca2+ into- or a reduced Ca2+ efflux from- the myoplasm. The possibility 
that MCa produced an extra- Ca2+ influx across the plasma membrane following a step 
membrane depolarization is unlikely because there was no specific change in the membrane 
current during and after the pulses in the MCa-injected fibers, as compared to the control 
ones. This is illustrated in Fig. 3 which shows indo-1 calcium transients and corresponding 
membrane current traces displayed at a high y scale magnification, elicited by three 
consecutive 5 ms-long pulses to +10 mV applied to a control fiber (Fig. 3A) and to an MCa-
injected fiber (Fig. 3B). Whereas the presence of MCa induced a very reproducible long-
lasting Ca2+ elevation after each of the pulses, the membrane current traces were very similar 
to those from the control fiber. Using data from the fibers used in Fig. 1, the mean change in 
membrane current ∆I (from the pre-pulse holding level) measured at the end of the 10 ms-
long pulses was –0.21 ± 0.3 (n=3), 0.72 ± 0.41 (n=5) and 1.46 ± 0.8 (n=5) A/F in control 
fibers, MCa-injected fibers and [Ala24]MCa-injected fibers, respectively. When measured 1 s 
after the pulse, ∆I was –0.024 ± 0.006 (n=5), -0.021 ± 0.004 (n=9) and –0.01 ± 0.004 A/F 
(n=5), in the same groups, respectively. For the two sets of measurements there was no 
significant difference between the three groups.  
Furthermore, in 3 fibers injected with MCa we took measurements in the presence and 
in the absence of extracellular calcium. For this each tested cell was superfused continuously 
with the extracellular solution using a polyethylene capillary perfusion system operated by 
gravity. Figure 4 shows membrane currents and indo-1 calcium signals measured from one of 
these fibers in response to a 20 ms long voltage step to +10 mV in the control condition (left), 
in the absence of extracellular calcium (replaced by magnesium, middle) and after returning 
to the control calcium containing solution (wash, right). The membrane current records are 
presented on an expanded x scale for clarity. They were corrected for the passive linear 
components by subtracting the adequately scaled current measured in response to a 20 mV 
hyperpolarization. The membrane current traces in the presence of the control external 
solution clearly exhibit a negative inward phase due to the activation of the slow inward 
calcium current (see for instance 30). As expected this current was lost in the absence of 
extracellular calcium but there was no simultaneous effect on the amplitude of the post-pulse 
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sustained phase of [Ca2+] elevation that resulted from the presence of MCa. In the 3 fibers 
tested the peak change in Ca2+ measured 1 s after the end of the pulse in the absence of 
extracellular calcium corresponded to 86 ± 9 % of the value measured before in the presence 
of extracellular calcium. We believe that this definitely excludes the possibility of a 
significant contribution of external calcium to the effect of MCa.  
 
The MCa-induced post-pulse elevated Ca2+ level was thus of intracellular origin. Since 
the phenomenon was only triggered upon voltage activation of the fibers and because the 
initial fast decline of the calcium transients appeared unaffected, there is little doubt that the 
underlying mechanism was a transient dysfunction of SR Ca2+ release. This of course is also 
in agreement with the results from previous measurements on SR vesicles and single 
ryanodine receptor channels that showed a selective effect of MCa on the calcium release 
channel activity with no concurrent alteration of the SERCA-mediated Ca2+ uptake (14, 29). 
The features of the MCa-induced post pulse Ca2+ elevation are consistent with a slowly 
decaying extra- phase of Ca2+ release proceeding for seconds following membrane 
repolarization. This is simulated in Fig. 5 using a model of calcium distribution (see 
Methods). Figure 5A shows synthetic Ca2+ release flux traces in control conditions (thin trace) 
and in the presence of MCa (thick trace). The inset in Fig. 5A shows an enlarged view of the 
Ca2+ release flux traces assumed to be activated by the depolarizing voltage step (V).  The 
Ca2+ flux waveform was made to have an early transient component that spontaneously 
decayed during the pulse towards a steady level. Upon repolarization, the flux was made to 
turn off with a time constant of 3 ms. Figure 5B shows the same traces on a longer time scale. 
The control and the MCa flux traces were made to be identical until the end of the pulse; 
thereafter the difference between the two was the presence of an additional small slowly 
decaying extra-phase of Ca2+ release in the MCa trace. This slowly decaying component was 
simulated as having a single exponential time course with a time constant of 8 s and an 
amplitude of 0.2 µM/ms. Figure 5C and Fig. 5D show the indo-1 saturation traces calculated 
from the above fluxes on a short and a long time scale, respectively. Results clearly show that 
a slowly decaying post-pulse extra-Ca2+ flux can well account for the results obtained in the 
presence of MCa. We also took advantage of the simulation to quantitatively estimate the 
amplitude of the transmembrane calcium current that would have been necessary to account 
for the observed effect of MCa (if the effect were to be solely due to Ca2+ entry across the 
plasma membrane). Using a value of 40 µm for the diameter of the voltage-clamped end 
portion of the fiber and assuming a ratio of capacitance to apparent membrane surface of 5 
µF/cm2 (21, 30) and a fraction of total fiber volume accessible to Ca2+ of 0.7, the MCa-
induced extra-Ca2+ input flux of 0.2 µM/ms peak amplitude in Fig. 5 would have 
corresponded to a peak transmembrane calcium current of ~5 A/F amplitude. Since such a 
current was clearly absent from the records obtained in the presence of MCa (Fig. 3) this 
possibility was definitely discarded, in accordance with the results from Fig. 4. 
 
As already pointed out in Fig. 1 and also observable in Fig. 2 a specific feature of the 
MCa effect was that the amplitude of the post-pulse [Ca2+] elevation was larger as the pulse 
duration was increased, indicating that the size of the post-pulse uncontrolled Ca2+ flux 
depended upon the previous extent of voltage-dependent Ca2+ release activation. This was 
also true when, for a same duration, the pulse amplitude was increased within the voltage 
range of activation of Ca2+ release (see Fig. 6A). This suggests that the more release channels 
are activated by voltage, the more will potentially be affected by MCa and remain open after 
membrane repolarization. Despite its impressive effect on the post-pulse [Ca2+] level, MCa 
seemed to only marginally, if at all, affect Ca2+ release during the depolarizing pulses. As an 
example, Fig. 6 shows the results from experiments aimed at comparing the voltage 
dependence of Ca2+ release between control and MCa-injected fibers. Indo-1 Ca2+ signals 
were recorded in response to the pulse protocol shown at the top of Fig. 6A. It consisted of a 
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sequence of 3 consecutive step depolarizations of 30 ms duration to the indicated values; each 
pulse was then incremented by 5 mV and the sequence was repeated. Figure 6A shows an 
example of corresponding indo-1 saturation signals in a control fiber and in an MCa injected 
fiber while Fig. 6B shows the Ca2+ release traces (d[Ca]T/dt, see Methods) calculated from the 
above transients. For clarity only the release flux trace calculated from the last sequence of 
indo-1 transients (in response to the pulses to –30, -10 and +10 mV) is shown. Although 
during a single sequence the sustained post-pulse [Ca2+] level in the presence of MCa may 
have affected the properties of Ca2+ release during the next pulse, the voltage level for both 
threshold and maximal activation of Ca2+ release were similar in the two fibers. The mean 
voltage dependence of the peak Ca2+ release flux from identical experiments in 3 control 
fibers and 4 MCa-injected fibers is shown in Fig. 6C. Superimposed curves were calculated 
with the mean parameters obtained from fitting a Boltzmann function to the individual series 
of data points in each fiber. Mean corresponding values for the peak release flux, midpoint 
voltage and steepness factor were 7.1 ± 0.6 µM/ms, -22 ± 2 mV and 4.6 ± 0.3 mV in control 
fibers and 5.4 ± 0.5 µM/ms, –17.3 ± 3 mV, 3.8 ± 0.1 mV in MCa-injected fibers, respectively. 
Mean values for the peak release flux and midpoint voltage did not significantly differ while 
the steepness factor was slightly but significantly reduced in the presence of MCa (P=0.05). 
Figure 6D presents the voltage dependence of the mean values for the post-pulse release flux 
in the control and in the MCa-injected fibers; values were measured 500 ms following the 
onset of each pulse (time indicated by the open arrows in panel B). In the MCa-injected fibers 
the amplitude of the post-pulse flux clearly had a voltage dependence similar to that of the 
peak release flux, whereas the control fibers exhibited no residual post-pulse flux. The strong 
dependence of the amplitude of the post-pulse release flux upon the amplitude of the peak 
flux is further illustrated in Fig. 6E where corresponding individual values for these two 
parameters were plotted versus each other. Fitting a straight line through the individual series 
of MCa data points in each fiber indicated that the post-pulse release flux corresponded to 4.3 
± 0.005 % of the peak flux activated during the pulse. 
 
Since MCa presents some homology with domain A of the II-III loop of the α1 subunit 
of the DHPr, it was of particular interest to directly test the effect of domain A under the 
present conditions. A series of measurements was thus performed with fibers micro-injected 
with a synthetic domain A peptide (see Methods). Figure 7 illustrates a series of results from 
these experiments; this figure is organized in the same format as Figure 1 in order to ease the 
comparison. Figure 7A shows superimposed indo-1 calcium signals elicited by step 
depolarizations of 10, 20 and 50 ms duration to +10 mV in a control fiber an in a fiber 
injected with the domain A peptide. The graphs give mean values for the corresponding 
baseline [Ca2+] level (Fig. 7B), the peak ∆[Ca2+] during the pulse (Fig. 7C), the ∆[Ca2+] 
measured 0.92 s (referred to as 1 s) after the onset of the pulses (Fig. 7D) and the ratio of 
∆[Ca2+] measured 1 s after the pulse (∆[Ca2+]1s) to the preceding peak ∆[Ca2+] (Fig. 7E). The 
y scale in panels B, D and E is the same as in the corresponding panels of Figure 1. Data are 
from 4 control fibers and 4 fibers injected with peptide A. Obviously, the presence of peptide 
A in the intracellular medium did not produce any reproducible alteration in the properties of 
the Ca2+ transients that would be consistent with the effect of MCa. 
 
 
DISCUSSION 
The present results show that during physiological excitation-contraction coupling, the 
step of repolarization-induced closure of the Ca2+ release channels is transiently disrupted by 
MCa, a toxin peptide that exhibits some homology with the domain A of the II-III loop of the 
DHPr in terms of both amino acid sequence (13) and three-dimensional structure (31). MCa 
was previously shown to have potentiating or activating effects on [3H]ryanodine binding to- 
and Ca2+ release from- SR vesicles, on isolated RYr channel activity, on Ca2+ release from 
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intact myotubes and on spontaneous Ca2+ release events in permeabilized muscle fibers (13, 
14, 19, 29). More recently MCa and domain A were shown to share common binding sites on 
RYr1 (20) which, added to the fact that MCa effect on RYr1 is clearly inhibited by domain A 
(29), would provide convincing support for the possibility that the two act on the same target 
through an analogous mechanism. The fact that the inhibition did not correspond to a simple 
competitive process (29) is likely to be due to the complexity of the overall mechanism 
because of the presumable 4:1 stoichiometry of the MCa (or domain A) -RYr1 interaction.  
Here we show that, within the physiological operating mode of e-c coupling of an 
intact mammalian skeletal muscle fiber, MCa forces Ca2+ release channels to remain open 
following a transient membrane depolarization. The effect of MCa was specific because a 
single amino-acid substitution (Arg24 by an alanine), previously shown to prevent MCa 
alteration of RYr1 activity (14), induced the loss of its effectiveness. The simplest conclusion 
from our results is that repolarization-induced closure of MCa-modified RYr channels is 
temporarily impaired. At this point two alternatives may be considered.  
The first possibility would be that the effects of MCa arise from its homology with 
domain A and tell us something about the dynamic physiological interactions that take place 
between the DHPr and the RYr during e-c coupling. In this framework however, one may 
have expected an excess of free peptide A in the myoplasm to produce a similar effect to that 
of MCa. In contrast, fibers injected with a synthetic domain A peptide did not exhibit a 
sustained Ca2+ elevation following a step depolarization. This makes it hard to further argue in 
favor of this first hypothesis although it remains possible that the synthetic domain A peptide 
does not yield the exact native functional configuration of the corresponding endogenous 
segment within the II-III loop or that the exogenous domain A is functional but acts in an 
undistinguishable manner from the endogenous one. Alternatively, the difference observed 
here between peptide A and MCa in terms of functional effect may be related to the 
biochemical and single channel data indicating that peptide A does not compete with MCa 
(29) or IpTx A (32) for certain effects on the ryanodine receptor. Finally, although here we 
did not detect any obvious effect of peptide A, it should be mentioned that in mechanically 
skinned rat skeletal muscle fibers with functional excitation-contraction coupling, peptide A 
was reported to elicit small spontaneous force responses in some fibers and to potentiate 
responses to depolarization in all fibers (33). 
Despite the sequence homology between domain A of the DHPr and MCa and their 
common binding site on the RYr, it is also possible that MCa acts through a mechanism that 
is independent from the function of domain A. Since the toxin had no detectable effect on 
resting [Ca2+] in the absence of depolarization, MCa is likely to have poor access to its 
binding site under resting conditions. Depolarization-induced opening of the RYr channels 
most likely then reveals the MCa binding site, allowing interaction with the toxin. Ca2+ 
transients exhibited no major alteration during the depolarizing pulses in the presence of 
MCa: the absolute peak amplitude of the transients and the voltage dependence of Ca2+ 
release were similar to those observed under control conditions. MCa thus does not appear to 
strongly impair the functional operating mode of the overall population of RYr channels once 
the membrane is depolarized. This may indicate that MCa-bound channels behave normally 
during the depolarization though one also cannot exclude the possibility that the fraction of 
MCa-bound channels was low enough that even if operating in an altered mode their 
contribution would be too little to seriously affect the overall release flux during the pulse. 
Conversely, membrane repolarization clearly reveals the activity of the MCa-bound channels. 
Once bound, MCa thus likely prevents the conformational change required for channel 
closure upon membrane repolarization. In that sense MCa could be pictured to act in an 
analogous way as ryanodine which, as we have previously showed, produces a use-dependent 
increase in SR Ca2+ leak due to RYr channels remaining locked open after a transient 
membrane depolarization (23). A noticeable difference is, however, that MCa-modified 
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channels eventually return to a normal gating mode, presumably due to the dissociation of 
MCa, as indicated by the return of intracellular [Ca2+] to its resting level.  
The present effect of MCa has a striking similarity with a previously described 
alteration of e-c coupling in frog skeletal muscle where low myoplasmic [Mg2+] levels could 
also induce a long-lasting elevation of myoplasmic [Ca2+] following a transient membrane 
depolarization (34). The similarity with the present effect of MCa may be indicative that the 
putative site for Mg2+ inhibition of Ca2+ release is somehow linked to the MCa binding site. 
 
In conclusion, this work demonstrates that the scorpion venom toxin MCa specifically 
alters the physiological process of repolarization-induced closure of the RYr channels. Further 
investigation of the properties of this effect will certainly prove helpful to unravel the 
molecular steps involved in the control of the RYr channels during excitation-contraction 
coupling.  
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FIGURE LEGENDS 
 
Figure 1. Incomplete decay of step depolarization-activated Ca2+ transients in 
MCa-injected fibers. A, indo-1 saturation transients elicited by consecutive depolarizing 
steps of 10, 30 and 50 ms duration to +10 mV in a control fiber (top) in an MCa-injected fiber 
(middle) and in a fiber injected with the mutated analog [Ala24]MCa. B, mean values for the 
baseline [Ca2+] level in control (n=5), MCa-injected (n=9) and [Ala24]MCa-injected fibers 
(n=5) challenged by a 10 and a 30 ms-long pulse to +10 mV. C and D, corresponding values 
for the peak ∆[Ca2+] and the ∆[Ca2+] measured ~1 s after the onset of the pulse, respectively. 
E, corresponding mean values for the ratio of the ∆[Ca2+] measured ~1 s after the onset of the 
pulse (mean shown in C) to the peak ∆[Ca2+] during the pulse (mean shown in D). See text for 
details. 
 
Figure 2. The long lasting [Ca2+] elevation following the end of a step 
depolarization in MCa-injected fibers. Traces correspond to indo-1 saturation records of 15 
s duration in a control fiber and in two MCa-injected fibers depolarized by short pulses to +10 
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mV of various duration. Pulses of 5 and 10 ms duration were applied in the control fiber 
(left). Pulses of 5, 10 and 30 ms duration were applied in the two MCa-injected fibers.  
 
Figure 3. The MCa-induced long-lasting post-pulse [Ca2+] elevation is not 
associated with a change in the holding membrane current. In A and B, the top series of 
traces correspond to successive (from left to right) indo-1 saturation transients elicited by a 5 
ms long pulse to +10 mV in a control fiber (A) and in an MCa-injected fiber (B); the bottom 
series of traces show the corresponding membrane current records at a high gain.  
 
Figure 4. The MCa-induced long-lasting post-pulse [Ca2+] elevation persists in the 
absence of extracellular calcium. All records are from the same fiber injected with MCa. 
The top series of traces corresponds to the changes in membrane current elicited by a 20 ms 
long pulse to +10 mV. The indo-1 calcium signals measured simultaneously are shown 
underneath on a more compressed time scale. Records were taken in the presence of the 
control extracellular solution (left), in the absence of extracellular calcium (middle) and after 
returning to the calcium containing control solution (right). Membrane current records were 
corrected for the linear components. 
 
Figure 5. Simulation of the effect of MCa using a simple model of intracellular 
Ca2+ distribution. A and B, synthetic Ca2+ release flux traces in control conditions (thin trace) 
and in the presence of MCa (thick trace). In A and B the same traces are shown on a short and 
long time scale, respectively. In A, the inset focuses on the peak phase of the release traces. In 
B, the inset shows the two traces on an expanded y scale. The only difference between the 
control and the MCa trace is the presence of a small slowly decaying extra- phase of Ca2+ 
release in the presence of MCa. This extra phase is best seen in the inset of panel B. C and D, 
corresponding calculated indo-1 saturation traces on a short and a long time scale, 
respectively.  
Figure 6. Voltage dependence of Ca2+ release in control fibers and in MCa-
injected fibers. A, indo-1 saturation transients measured in response to the pulse protocol 
illustrated on top, in a control fiber (left) and in an MCa-injected fiber (right). The protocol 
consisted of a sequence of 3 consecutive step depolarizations of 30 ms duration. During the 
first sequence the 3 successive steps were to –50, -30 and –10 mV, respectively. The 
amplitude of each of the 3 steps was then incremented by 5 mV and the sequence was 
repeated. The sequence was applied 5 times so that during the last run the 3 steps were to –30, 
-10 and +10 mV, respectively.  Indo-1 transients obtained in response to the 5 sequences are 
shown superimposed. B, Ca2+ release flux calculated from the above indo-1 transients; only 
the release flux from the indo-1 trace obtained in response to the successive pulses to –30, -10 
and +10 mV is shown. The y scale bar in each panel corresponds to 1 µM/ms. The horizontal 
dotted line corresponds to the initial baseline level. Filled and open arrows point to the peak 
and post-pulse release flux levels that were measured, respectively; amplitudes were 
measured from the pre-pulse level. The post-pulse flux values were taken as the average from 
a 100 ms long portion of trace, 500 ms following the pulse onset. The mean from these 
measurements is reported in the following panels. C, mean voltage dependence of the peak 
Ca2+ release flux in control fibers (filled circles, n=3) and in MCa-injected fibers (open 
circles, n=4). D, corresponding mean voltage dependence of the post-pulse Ca2+ release flux. 
E,  plot of the individual values of the post-pulse release flux versus the corresponding peak 
release flux in the control (filled symbols) and the MCa-injected fibers (open symbols). 
Different symbols correspond to the different fibers.  
 
Figure 7. Voltage-activated Ca2+ transients in fibers injected with a synthetic 
peptide corresponding to domain A of the II-III loop of the DHPr α1 subunit. A, indo-1 
saturation transients elicited by consecutive depolarizing steps of 10, 20 and 50 ms duration to 
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+10 mV in a control fiber (top) and in a peptide A-injected fiber (bottom). B, mean values for 
the baseline [Ca2+] level in control (n=4) and peptide A-injected fibers (n=4) challenged by 
the pulse protocol shown in A. C and D, corresponding values for the peak ∆[Ca2+] and the 
∆[Ca2+] measured ~1 s after the onset of the pulse, respectively. E, corresponding mean 
values for the ratio of the ∆[Ca2+] measured ~1 s after the onset of the pulse (mean shown in 
C) to the peak ∆[Ca2+] during the pulse (mean shown in D).  
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